K-numberK243359
Device nameMagDI System (MAG-02, DS-01)
ApplicantGt Metabolic Solutions, Inc.
Product codeSAH
Device classClass II
Decision dateFeb 28, 2025
DecisionSubstantially Equivalent
Regulation878.4816
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The MagDI System is a sterile, single-use magnetic compression anastomosis device consisting of two magnets used to create side-to-side duodeno-ileal anastomoses (bowel connections) during minimally invasive and laparoscopic surgery. After 7–21 days, the magnets compress tissue between them, causing necrosis; the device then naturally detaches and is expelled. It is intended for adult patients over 21 years old.

Technological characteristics

The subject device (MAG-02, 50mm length) is a planned variant of the predicate device (MAG-01, 39mm length). The sole change is increased magnet length while maintaining similar compression strength. Both devices use the same fundamental magnetic compression anastomosis technology, intended use, and indications for use. The longer magnet provides surgeons flexibility to choose device length based on individual patient morphology and clinical characteristics.

Test standards cited

ISO 10993-1 (biocompatibility), ISO 11137-1, ISO 11137-2, and ISO 11137-3 (sterilization validation with sterility assurance level of 10^-6), and ISO 15223 (labeling symbols). The device demonstrated magnet field strength safety, adequate separation forces over use life, and successful connection/disconnection to the delivery system.

Substantial equivalence argument

The subject device is substantially equivalent because it maintains identical intended use and indications for use as the predicate (K242086), employs the same fundamental magnetic compression anastomosis technology without fundamental changes, and the sole modification—increased magnet length—does not raise new safety or effectiveness questions. Clinical testing in obese patients demonstrated successful anastomosis creation with a safety profile as least as safe as the predicate, with no cases of internal hernia, bowel obstruction, anastomotic complications, or deaths. The device will be incorporated into the same post-market surveillance study as the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →